Susquehanna International Group, LLP Catalyst Pharmaceuticals, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$527 Billion
Q2 2024

Call Options

22 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 15, 2024	BUY	$14.68 - $16.92 $136,524 - $157,356	9,300 Added 80.87%	20,800 $322,000
Q1 2024 May 07, 2024	BUY	$13.18 - $17.11 $151,570 - $196,765	11,500 New	11,500 $183,000
Q3 2023 Nov 14, 2023	SELL	$11.69 - $15.02 $423,178 - $543,724	-36,200 Reduced 74.18%	12,600 $147,000
Q2 2023 Aug 11, 2023	SELL	$11.5 - $18.08 $2.01 Million - $3.16 Million	-174,900 Reduced 78.19%	48,800 $655,000
Q1 2023 May 16, 2023	BUY	$14.34 - $21.05 $354,198 - $519,935	24,700 Added 12.41%	223,700 $3.71 Million
Q4 2022 Feb 14, 2023	BUY	$12.25 - $19.5 $2.21 Million - $3.51 Million	180,000 Added 947.37%	199,000 $3.7 Million
Q3 2022 Nov 14, 2022	BUY	$7.06 - $15.52 $134,140 - $294,880	19,000 New	19,000 $244,000
Q3 2021 Nov 15, 2021	SELL	$4.85 - $6.04 $134,830 - $167,912	-27,800 Reduced 68.98%	12,500 $66,000
Q2 2021 Aug 11, 2021	BUY	$4.29 - $6.05 $86,229 - $121,605	20,100 Added 99.5%	40,300 $232,000
Q1 2021 May 17, 2021	SELL	$3.45 - $4.69 $14,490 - $19,698	-4,200 Reduced 17.21%	20,200 $93,000
Q4 2020 Feb 16, 2021	SELL	$2.97 - $3.83 $266,706 - $343,934	-89,800 Reduced 78.63%	24,400 $81,000
Q3 2020 Nov 16, 2020	BUY	$2.97 - $5.08 $38,907 - $66,548	13,100 Added 12.96%	114,200 $339,000
Q2 2020 Aug 14, 2020	BUY	$3.48 - $5.05 $39,324 - $57,065	11,300 Added 12.58%	101,100 $467,000
Q1 2020 May 15, 2020	BUY	$2.61 - $5.21 $175,392 - $350,112	67,200 Added 297.35%	89,800 $346,000
Q3 2019 Nov 14, 2019	SELL	$3.89 - $7.43 $533,708 - $1.02 Million	-137,200 Reduced 85.86%	22,600 $120,000
Q2 2019 Aug 14, 2019	BUY	$2.7 - $6.11 $158,760 - $359,268	58,800 Added 58.22%	159,800 $614,000
Q1 2019 May 15, 2019	SELL	$2.11 - $5.33 $228,513 - $577,239	-108,300 Reduced 51.74%	101,000 $515,000
Q3 2018 Nov 14, 2018	BUY	$2.81 - $3.78 $426,839 - $574,182	151,900 Added 264.63%	209,300 $791,000
Q2 2018 Aug 14, 2018	BUY	$2.26 - $3.84 $72,998 - $124,032	32,300 Added 128.69%	57,400 $179,000
Q1 2018 May 15, 2018	BUY	$2.39 - $4.01 $29,875 - $50,125	12,500 Added 99.21%	25,100 $60,000
Q4 2017 Feb 14, 2018	SELL	$2.51 - $4.4 $24,848 - $43,560	-9,900 Reduced 44.0%	12,600 $49,000
Q3 2017 Nov 14, 2017	BUY	$2.4 - $2.94 $54,000 - $66,150	22,500	22,500 $57,000

Others Institutions Holding CPRX

# of Institutions

285

Shares Held

96.6M

Call Options Held

29.2K

Put Options Held

20.5K

Black Rock Inc. New York, NY

18.7M
Shares

$372 Million
0.01% of portfolio
Deerfield Management Company, L.P. (Series C) New York, NY

9.13M
Shares

$181 Million
2.97% of portfolio
Vanguard Group Inc Valley Forge, PA

8.1M
Shares

$161 Million
0.0% of portfolio
State Street Corp Boston, MA

6.03M
Shares

$120 Million
0.0% of portfolio
Dimensional Fund Advisors LP Austin, TX

3M
Shares

$59.7 Million
0.01% of portfolio

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.04B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account